Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02387840
What this trial is testing

Feasibility and Clinically Application of Magnetic Resonance Fingerprinting

Who this might be right for
Neurofibromatosis Type 1Brain TumorGlioma
Case Comprehensive Cancer Center 35
Not applicableStudy completedNCT02153931
What this trial is testing

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT06120036
What this trial is testing

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03504501
What this trial is testing

Synaptic Plasticity and Cognitive Function in RASopathies

Who this might be right for
Impaired Synaptic PlasticityImpaired Cognition
Technical University of Munich 16
Not applicableStudy completedNCT03531814
What this trial is testing

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT05253131
What this trial is testing

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Who this might be right for
MPNSTNF1Sarcoma
University of Alabama at Birmingham 41
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07024394
What this trial is testing

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Plexiform NeurofibromaNF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT02407405
What this trial is testing

MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1 (NF1)Plexiform Neurofibromas (PN)
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT05377008
What this trial is testing

Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1

Who this might be right for
Neurocognitive DeficitMental Health ImpairmentNeurofibromatosis 1
Virginia Commonwealth University 38
Not applicableUnknownNCT03981510
What this trial is testing

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Who this might be right for
ConstipationChildhood Acute Lymphoblastic LeukemiaNeurofibromatosis 1+1 more
University of Aarhus 80
Testing effectiveness (Phase 2)Ended earlyNCT01968590
What this trial is testing

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1 (NF1)
University of Utah 26
Early research (Phase 1)Active Not RecruitingNCT05101148
What this trial is testing

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 24
Not applicableUnknownNCT01626846
What this trial is testing

How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem

Who this might be right for
Neurofibromatosis Type 1
John Jay High School 50
Early research (Phase 1)Looking for participantsNCT06502171
What this trial is testing

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
Girish Dhall, MD 30
Not applicableWithdrawnNCT03332030
What this trial is testing

Stem Cells in NF1 Patients With Tumors of the Central Nervous System

Who this might be right for
Neurofibromatosis Type 1Tumors of the Central Nervous System
Roger Packer
Early research (Phase 1)Study completedNCT02700230
What this trial is testing

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Peripheral Nerve Sheath TumorNeurofibromatosis Type 1Recurrent Malignant Peripheral Nerve Sheath Tumor
Mayo Clinic 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621082
What this trial is testing

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

Who this might be right for
Neurofibromatosis 1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03962543
What this trial is testing

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Who this might be right for
Plexiform NeurofibromaNeurofibromatosis Type 1 (NF1)
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 114
Not applicableUnknownNCT03518710
What this trial is testing

Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Toulouse 15
Next Page